2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

  • Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0J704
  • Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0J705
  • Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0J70M
  • Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0J728
  • Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0J729
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0J73Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0J76Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0J77Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0J7BZ
  • Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0J7GC
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0J7HZ
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0J7KZ
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0J7NZ
  • Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0J7SF
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0J7TZ
  • Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Approach - 3E0J7U0
  • Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Approach - 3E0J7U1
  • Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0J804
  • Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0J805
  • Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0J80M
  • Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0J828
  • Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0J829
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0J83Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0J86Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0J87Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8BZ
  • Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8GC
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8HZ
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8KZ
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8NZ
  • Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8SF
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8TZ
  • Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8U0
  • Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Endoscopic Approach - 3E0J8U1
  • Introduction Genitourinary Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0K304
  • Introduction Genitourinary Tract to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0K305
  • Introduction Genitourinary Tract to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0K30M
  • Introduction Genitourinary Tract to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0K328
  • Introduction Genitourinary Tract to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0K329
  • Introduction Genitourinary Tract to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0K33Z
  • Introduction Genitourinary Tract to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0K36Z
  • Introduction Genitourinary Tract to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0K37Z
  • Introduction Genitourinary Tract to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0K3BZ
  • Introduction Genitourinary Tract to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0K3GC
  • Introduction Genitourinary Tract to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0K3HZ
  • Introduction Genitourinary Tract to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0K3KZ
  • Introduction Genitourinary Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0K3NZ
  • Introduction Genitourinary Tract to Other Gas with Gas, Percutaneous Approach - 3E0K3SF
  • Introduction Genitourinary Tract to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0K3TZ
  • Introduction Genitourinary Tract to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0K4GC
  • Introduction Genitourinary Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0K704
  • Introduction Genitourinary Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0K705
  • Introduction Genitourinary Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0K70M
  • Introduction Genitourinary Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0K728
  • Introduction Genitourinary Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0K729
  • Introduction Genitourinary Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0K73Z
  • Introduction Genitourinary Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0K76Z
  • Introduction Genitourinary Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0K77Z
  • Introduction Genitourinary Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0K7BZ
  • Introduction Genitourinary Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0K7GC
  • Introduction Genitourinary Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0K7HZ
  • Introduction Genitourinary Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0K7KZ
  • Introduction Genitourinary Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0K7NZ
  • Introduction Genitourinary Tract to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0K7SF
  • Introduction Genitourinary Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0K7TZ
  • Introduction Genitourinary Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0K804
  • Introduction Genitourinary Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0K805
  • Introduction Genitourinary Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0K80M
  • Introduction Genitourinary Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0K828
  • Introduction Genitourinary Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0K829
  • Introduction Genitourinary Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0K83Z
  • Introduction Genitourinary Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0K86Z
  • Introduction Genitourinary Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0K87Z
  • Introduction Genitourinary Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8BZ
  • Introduction Genitourinary Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8GC
  • Introduction Genitourinary Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8HZ
  • Introduction Genitourinary Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8KZ
  • Introduction Genitourinary Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8NZ
  • Introduction Genitourinary Tract to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8SF
  • Introduction Genitourinary Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0K8TZ
  • Introduction Pleural Cavity to No Qualifier with Adhesion Barrier, Open Approach - 3E0L05Z
  • Introduction Pleural Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0L304
  • Introduction Pleural Cavity to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0L305
  • Introduction Pleural Cavity to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0L30M
  • Introduction Pleural Cavity to Other Thrombolytic with Thrombolytic, Percutaneous Approach - 3E0L317
  • Introduction Pleural Cavity to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0L328
  • Introduction Pleural Cavity to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0L329
  • Introduction Pleural Cavity to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0L33Z
  • Introduction Pleural Cavity to No Qualifier with Adhesion Barrier, Percutaneous Approach - 3E0L35Z
  • Introduction Pleural Cavity to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0L36Z
  • Introduction Pleural Cavity to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0L37Z
  • Introduction Pleural Cavity to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0L3BZ
  • Introduction Pleural Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0L3GC
  • Introduction Pleural Cavity to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0L3HZ
  • Introduction Pleural Cavity to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0L3KZ
  • Introduction Pleural Cavity to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0L3NZ
  • Introduction Pleural Cavity to Other Gas with Gas, Percutaneous Approach - 3E0L3SF
  • Introduction Pleural Cavity to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0L3TZ
  • Introduction Pleural Cavity to No Qualifier with Adhesion Barrier, Percutaneous Endoscopic Approach - 3E0L45Z
  • Introduction Pleural Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0L4GC